Poor prognosis of NSCLC patients with activated NOTCH signaling (either by NOTCH receptor activating mutations or loss of NUMB repressor) has been associated with absence of mutations in the tumor suppressor protein TP53 (74). Here, TP53 is linked to non-small cell lung carcinoma.